Difference between revisions of "CH Basel Balavenkatraman KK"
From Bioblast
m (moved CH Basel ChiesiM to CH Basel Chiesi M) |
Beno Marija (talk | contribs) Β |
||
(12 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
{{ | {{O2k-Network Lab | ||
| | |institution=Investigator II (iTox-PCS) - Novartis Pharma Ltd., WKL-135.3.21 | ||
Β | |address=Klybeckstr 191 | ||
Novartis Pharma Ltd. | |area code=4057 | ||
Β | |||
WKL- | |||
Β | |||
|city=Basel | |city=Basel | ||
|country=Switzerland | |country=Switzerland | ||
|MiPNetLab=Chiesi | |Contact=Balavenkatraman Kamal Kumar | ||
|MiPNetLab=Grueninger Stephan | |||
|Team previous=Chiesi Michele, Weiss Alexander | |||
|Status=O2k 2007 β | |||
|info=[[IOC106]], [[IOC39]] | |||
|Info=[http://www.oroboros.at/index.php?id=1215 CH_Basel_ChiesiM] | |Info=[http://www.oroboros.at/index.php?id=1215 CH_Basel_ChiesiM] | ||
}} | }} | ||
* Previously CH_Basel_Chiesi M |
Latest revision as of 11:39, 14 May 2019
CH Basel Balavenkatraman KK
O2k-Network Lab | Investigator II (iTox-PCS) - Novartis Pharma Ltd., WKL-135.3.21 |
---|---|
Address | Klybeckstr 191, 4057 |
City | Basel |
State/Prov | |
Country | Switzerland |
Weblink | |
Contact | Balavenkatraman Kamal Kumar |
Team | Grueninger Stephan |
Team previous | Chiesi Michele, Weiss Alexander |
Status | O2k 2007 β |
Oroboros Events | IOC106, IOC39 |
Topics |
O2k-Publications
update please
O2k-Abstracts
update please
- Previously CH_Basel_Chiesi M